Which patients presenting with clinical anxiety will abuse benzodiazepines?

Human Psychopharmacology

Volumn 14, Issue SUPPL. 1, 1999, Pages

  Van Valkenburg, Charles ^c   Akiskal, Hagop S ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NONE

Author keywords

Antisocial personality; Benzodiazepine abuse; Generalized anxiety; Panic disorder; Sedative abuse

Indexed keywords

ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; HYDROXYZINE; SEDATIVE AGENT; SEROTONIN UPTAKE INHIBITOR;

ALCOHOLISM; ANTISOCIAL BEHAVIOR; ANXIETY NEUROSIS; CONFERENCE PAPER; DRUG ABUSE; FAMILY HISTORY; HUMAN; HUMAN RELATION; HYSTERIA; INTERVIEW; MALADJUSTMENT; MOOD; PRIORITY JOURNAL; SOMATIZATION; SUICIDE ATTEMPT;

EID: 0032729755     PISSN: 08856222     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-1077(199908)14:1+3.0.CO;2-B     Document Type: Conference Paper

References (52)

1. Akiskal, H. S., Bitar, A. H., Puzantian, V. R., Rosenthal, T. L. and Walker, P. W. (1978). The nosological status of neurotic depression: a prospective three-to-four year examination in light of the primary-secondary and unipolar-bipolar dichotomies. Archives of General Psychiatry, 35, 756-766.
2. Allgulander, C. (1986). History and current status of sedative-hypnotic drug use and abuse. Acta Psychiatrica Scandinavica, 73, 465-478.
3. Allgulander, C. and Borg, S. (1978). Sedative-hypnotic and alcohol dependence among psychiatric inpatients. British Journal of Addiction, 73, 123-128.
4. Allgulander, C., Borg, S. and Vikander, B. (1984). A 4-6 year follow-up of 50 patients with primary dependence on sedative and hypnotic drugs. American Journal of Psychiatry, 141, 1508-1582.
5. Allgulander, C., Ljunberg, L. and Fisher, L. D. (1987). Long-term prognosis in addiction in sedative and hypnotic drugs analyzed with the Cox regression model. Acta Psychiatrica Scandinavica, 75, 521-531.
6. American Psychiatric Association (1992). Diagnostic and Statistical Manual, 4th ed. (DSM-IV). APA, Washington.
7. Anchersen, P. (1947). On the prognosis of narcomania (euphoromania). Acta Psvchiatrica Neurologica, 22, 153-192.
8. Baum, C., Forbes, M. B. and Kennedy, D. L. (1984). Psychotherapeutic drug use 1973-1983. Foster, American Psychological Association Annual Convention, Toronto.
9. Bush, P. J., Spector, K. K. and Rabin, D. L. (1984). Use of sedatives and hypnotics prescribed in a family practice. South Medical Journal, 77, 677-681.
10. Busto, U. E., Romach, M. K. and Sellers, E. M. (1996). Multiple drug use and psychiatric comorbidity in patients admitted to the hospital with severe benzodiazepine dependence. Journal of Clinical Psychopharmacology, 16, 51-57.
11. Brown, C. S., Rakel, R. E., Wells, B. G., Downs, J. and Akiskal, H. S. (1991). A practical update on anxiety disorders and their pharmacologic management. Archives of International Medicine, 151, 873-884.
12. Chambers, C. D. and White, O. Z. (1980). Characteristics of high-frequency consumers of prescription psychoactive drugs. Chemical Dependency, 4, 33-46.
13. Ciraulo, D. A., Sarid-Segal, O., Knapp, C., Ciraulo, A. M., Greenblatt, D. J. and Shader, R. I. (1996). Liability to alprazolam abuse in daughters of alcoholics. American Journal of Psychiatry, 153, 956-958.
14. Ciraulo, D. A., Barnhill, J. G., Ciraulo, A. M., Sarid-Segal, O., Knapp, C., Greenblatt, D. J. and Shader, R. I. (1997). Alterations in pharmacodynamics of anxiolytics in abstinent alcoholic men: subjective responses, abuse liability, and electroencephalographic effects of alprazolam, diazepam, and buspirone. Journal of Clinical Pharmacology, 37, 64-73.
15. deWitt, H., Johanson, C. E. and Uhlenhuth, E. H. (1984). The dependence potential of benzodiazepines. Current Medical Research Opinion, 8(suppl. 4), 48-59.
16. Dietch, J. (1983). The nature and extent of benzodiazepine abuse: an overview of recent literature. Hospital and Community Psychiatry, 34, 1145-1149.
17. Feighner, J. P., Robins, E. and Guze, S. (1972). Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57-63.
18. Ferreri, M. and Hantouche, E. G. (1988). Recent clinical trials of hydroxyzine in generalized anxiety disorder. Acta Psychiatrica Scandinavia, 98, 102-108.
19. Fleischhacker, W. W., Barnas, C. and Hackenberg, B. (1986). Epidemiology of benzodiazepine dependence. Acta Psychiatrica Scandinavica, 74, 80-83.
20. Garvey, M. J. and Tollefson, G. D. (1986). Prevalence of misuse of prescribed benzodiazepines in patients with primary anxiety disorder or major depression. American Journal of Psychiatry, 143, 1601-1603.
21. Gawin, F. H. and Markoff, R. A. (1981). Panic anxiety after abrupt discontinuation of amitriptyline. American Journal of Psychiatry, 138, 117-118.
22. Ghodse, A. H., London, M., Bewley, T. H. and Bhat, A. V. (1987). In-patient treatment for drug abuse. British Journal of Psychiatry, 151, 72-75.
23. Griffiths, R. R. and Weerts, E. M. (1997). Benzodiazepine self-administration in humans and laboratory animals - implications for problems of long-term use and abuse. Psychopharmacology, 134, 1-37.
24. Himmelhoch, J. M. (1986). Benzodiazepine dependence: a spectrum of clinical syndromes. In Proceedings -Anxiety Disorders: An International Update. Academy Professional Information Services, Inc., New York, pp. 53-64.
25. Hindmarch, I. (1988). Cognition and anxiety: the cognitive effects of anti-anxiety medication. Acta Psychiatrica Scandinavia, 98, 89-94.
26. Husquinet, H. (1981). Quarante ans de toxicomanie dans un hópital psychiatrique liègeois. Ann. Méd. Psychol. (Paris), 139, 1077-1095.
27. Kemper, N., Poser, W. and Poser, S. (1980). Benzodiazepine dependence: addiction potential of the benzodiazepines is greater than previously assumed. Dtsch Med. Wochenschr., 49, 1707-1712.
28. Kyneb, P. (1976). Prescriptions for psychotropic agents for a limited Danish island population during the five-year period 1968-1972. Ugeskr. Laeg, 138, 15331-15540.
29. Kyneb, P., Bjorn-Henriksen, T. and Bungaard, J. (1975). Prescription of tranquilizers in a limited non-institutionalized population illustrated by analysis of prescriptions: a preliminary account. Ugeskr. Laeg, 137, 2645-2652.
30. Lader, M. H. (1994). Benzodiazepines: a risk-benefit profile. CND Drugs, 1, 377-387.
31. Lader, M. H. and Peterson, H. (1981). Benzodiazepine derivatives - side effects and dangers. Biol. Psychiatry, 16, 1195-1201.
32. Lader, M. and Peterson, H. (1983). Long-term effects of benzodiazepines. Neuropsychopharmacology, 20 (suppl. 4), 527-533.
33. Ladewig, D. (1982). Abusus van benzodiazepin-tranquilizern. Ergebnis einer gesamtschweizerischen Erhebung bei Ärtzen in der Praxis. Med-Welt, 33, 1306-1309.
34. Ladewig, D. (1983). Abuse of benzodiazepines in western European society: incidence, motives, prevalence, drug acquisition. Pharmacopsychiatry, 16, 103-106.
35. Laux, G. and Konig, W. (1987). Long-term use of benzodiazepines in psychiatric inpatients. Acta Psychiatrica Scandinavica, 76, 64-70.
36. Lilienfeld, S. O., van Valkenburg, C., Larntz, K. and Akiskal, H. S. (1986). The relationship of histrionic personality to antisocial personality and somatization disorders. American Journal of Psychiatry, 143, 718-722.
37. Livingston, M. G. (1994). Benzodiazepine dependence. British Journal of Hospital Medicine, 51, 281-286.
38. Markowitz, J. S., Weissman, M. M., Ouellette, R., Lish, J. D. and Klerman, G. L. (1989). Quality of life in panic disorder. Archives of General Psychiatry, 46, 984-992.
39. Martínez-Cano, H., Vela-Bueno, A., De Iceta, M., Pomalima, R., Martínez-Gras, I. and Sobrino, M. P., (1996). Benzodiazepine types versus therapeutic dose dependence. Addiction, 91, 1179-1186.
40. Mueller, T. I., Goldenberg, I. M., Gordon, A. L., Keller, M. B. and Warshaw, M. G. (1996). Benzodiazepine use in anxiety disordered patients with and without a history of alcoholism. Journal of Clinical Psychiatry, 57, 83-89.
41. Neutel, C. I. and Patten, S. B. (1997). Risk of suicide attempts after benzodiazepine and/or antidepressant use. Annals of Epidemiology, 7, 568-574.
42. Norman, T. R., Ellen, S. R. and Burrows, G. D. (1997). Benzodiazepines in anxiety disorders: managing therapeutics and dependence. MJA, 167, 490-495.
43. Parssinen, T. M. and Kerner, K. (1980). Development of the disease model of drug addiction in Britain 1870-1926. Med. Hist., 24, 275-296.
44. Retterstol, N. and Sund, A. (1964). Drug addiction and habituation: an investigation with personal follow-up of 122 drug addicted and habituated patients previously treated in a psychiatric clinical department. Acta Psychiatrica Scandinavica, (suppl. 179).
45. Rickels, K., Schweizer, E., Case, G. and Greenblatt, D. J. (1990). Long-term use of benzodiazepines. I. Effects of abrupt discontinuation. Archives of General Psychiatry, 47, 899-907.
46. Romach, M., Busto, U., Somer, G., Kaplan, H. L. and Sellers, E. (1995). Clinical aspects of chronic use of alprazolam and lorazepam. American Journal of Psychiatry, 152, 1161-1167.
47. Samarasinghe, D. S., Tilley, S. and Marks, I. M. (1984). Alcohol and sedative use in neurotic outpatients. British Journal of Psychiatry, 145, 45-48.
48. Schmauss, C., Apelt, S. and Emrich, H. M. (1987). Characterization of benzodiazepine withdrawal in high- and low-dose dependent psychiatric inpatients. Brain Research Bulletin, 19, 393-400.
49. Schneider, F. R. and Siris, S. G. (1987). A review of psychoactive substance use and abuse in schizophrenia: patterns of drug choice. Journal of Nervous and Mental Disease, 175, 641-652.
50. Schweizer, E., Rickels, K., Case, G. and Greenblatt, D. J. (1990). Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper. Archives of General Psychiatry, 47, 908-915.
51. Spiegel, D. A. and Bruce, T. J. (1997). Benzodiazepines and exposure-based cognitive behavior therapies for panic disorder: conclusions from combined treatment trials. American Journal of Psychiatry, 154, 773-781.
52. Tennant, F. S. and Pumphrey, E. A. (1984). Benzodiazepine dependence of several years' duration: clinical profile and therapeutic benefits. National Institute of Drug Abuse Research Monograph Series, 55, 211-216.